Lumipulse® G TgAb (Anti-Thyroglobulin Antibodies)
Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of anti-thyroglobulin antibodies (TgAb) in serum or plasma. Includes calibrators.
The assay utilises proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
Product number 230558
-
Details
CLEIA - ChemiLuminescent Enzyme Immunoassay
Test principle: Two-Step sandwich assay
Clinical backgroundTgAb
Anti-thyroglobulin antibodies (ATA), or frequently referred to as TgAb, are frequently detected in the serum of patients with Graves’ or Hashimoto’s disease, which are known as autoimmune thyroid diseases.
These antibodies are clinically useful indicators in the diagnosis and monitoring of these diseases.
TgAb is an autoantibody directed against thyroglobulin, and therefore can have impact on these levels.
The TgAb level in blood has been reported to rise with myasthenia gravis or lupoid hepatitis, in addition to Graves’ or Hashimoto’s disease.
See the LUMIPULSE G1200 working in this video:
-
Documentation
Browse regulatory documents for this product
Create a (free!) eServices account and start browsing all regulatory documentation right away.
Get access to this section and more
Create a free eServices account now and instantly access multiple digital resources:
- Regulatory product documentation
- Selected scientific posters
- Product leaflets
- How-to videos and more…
-
FAQ
How does the coronavirus disease Covid-19 impact Fujirebio's operations?
Please see the following statement on the impact of coronavirus disease Covid-19 on the operations of Fujirebio Europe (updated January 19, 2021).
-
Related products
-
Product inquiry
